Key points are not available for this paper at this time.
It is known that a patient with a diagnosed autoimmune disorder has a predisposition for developing other autoimmune disorders. However, it is unknown when and which disorder can be developed. Some associations of autoimmune disorders are well documented, but others are barely studied due to their rarity of presentation. Overlapping of Immune Thrombocytopenic Purpura (ITP) and Grave's Disease has been described in case reports, but the appropriate treatment approach is unclear. Antithyroid drugs usually recommended for Grave's disease such as methimazole and PTU are known to have agranulocytosis as an adverse effect.
Velez et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: